Dual-functional nanovesicles simultaneously inhibit stromal fibrosis and angiogenesis to suppress cholangiocarcinoma progression

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Cholangiocarcinoma (CCA), the second most prevalent primary hepatic malignancy, demonstrates resistance to antiangiogenic therapy due possibly to the dynam
Funding Information
  • The National Natural Science Foundation of China (82303777)
  • National Key Research and Development Program of China (2022YFC2406704)
  • The National Key R&D Program of China (2023YFA0915400)
  • the national key Research and Development Program of China (2021YFA1201102)
  • National Natural Science Foundation of China (32370973)

This publication has 55 references indexed in Scilit: